INSP · Inspire Medical Systems, Inc. · Executive Compensation
$72.44
+1.10 (+1.54%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$2.06B
Shares
28.91M
Volume · Oct 21
12.78K
Avg daily vol (3M)
799.53K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Timothy Herbert | CEO | $7,711,784 |
| Timothy P. Herbert | President and Chief Executive Officer | $7,711,784 |
| Carlton W. Weatherby | Chief Strategy Officer | $2,835,087 |
| Randall A. Ban | Chief Commercial Officer | $2,729,287 |
| Richard Buchholz | Chief Financial Officer | $2,707,684 |
| Richard J. Buchholz | Chief Financial Officer | $2,707,684 |
| Bryan K. Phillips | SVP, General Counsel, CCO and Corporate Secretary | $2,702,484 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Timothy P. Herbert | President and Chief Executive Officer | $8,106,143 |
| Timothy Herbert | CEO | $8,106,143 |
| Carlton W. Weatherby | Chief Strategy Officer | $2,896,870 |
| Randall A. Ban | Chief Commercial Officer | $2,851,794 |
| Bryan K. Phillips | SVP, General Counsel, CCO and Secretary | $2,834,051 |
| Richard Buchholz | Chief Financial Officer | $2,824,625 |
| Richard J. Buchholz | Chief Financial Officer | $2,824,625 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Timothy P. Herbert | President and Chief Executive Officer | $7,490,775 |
| Timothy Herbert | CEO | $7,490,775 |
| Philip J. Ebeling | Chief Operating Officer | $2,320,484 |
| Richard J. Buchholz | Chief Financial Officer | $2,308,509 |
| Richard Buchholz | Chief Financial Officer | $2,308,509 |
| Carlton W. Weatherby | Chief Strategy Officer | $2,274,947 |
| Randall A. Ban | Chief Commercial Officer | $2,269,520 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Timothy Herbert | CEO | $5,675,394 |
| Timothy P. Herbert | President and Chief Executive Officer | $5,675,394 |
| Randall A. Ban | Chief Commercial Officer | $2,210,653 |
| Philip J. Ebeling | Chief Operating Officer | $2,147,557 |
| Richard Buchholz | Chief Financial Officer | $2,134,630 |
| Richard J. Buchholz | Chief Financial Officer | $2,134,630 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Timothy P. Herbert | President and Chief Executive Officer | $1,272,917 |
| Timothy Herbert | CEO | $1,272,917 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Timothy Herbert | CEO | $4,865,607 |
| Timothy P. Herbert | President and Chief Executive Officer | $4,865,607 |
| Philip J. Ebeling | Chief Operating Officer | $3,540,400 |
| Richard Buchholz | Chief Financial Officer | $2,161,622 |
| Richard J. Buchholz | Chief Financial Officer | $2,161,622 |
| Randall A. Ban | Chief Commercial Officer | $2,147,752 |
| Steven L. Jandrich | Chief Compliance Officer and Vice President Human Resources | $1,986,332 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Timothy Herbert | CEO | $2,899,563 |
| Timothy P. Herbert | President and Chief Executive Officer | $2,899,563 |
| Randall A. Ban | Chief Commercial Officer | $1,976,664 |
| Richard Buchholz | Chief Financial Officer | $1,150,836 |
| Richard J. Buchholz | Chief Financial Officer | $1,150,836 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Timothy Herbert | CEO | $3,260,769 |
| Timothy P. Herbert | President and Chief Executive Officer | $3,260,769 |
| Richard Buchholz | Chief Financial Officer | $1,158,832 |
| Richard J. Buchholz | Chief Financial Officer | $1,158,832 |
| Randall A. Ban | Chief Commercial Officer | $1,063,351 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Timothy P. Herbert | President and Chief Executive Officer | $599,561 |
| Timothy Herbert | CEO | $599,561 |
| Randall A. Ban | Chief Commercial Officer | $513,211 |
| Richard Buchholz | Chief Financial Officer | $329,672 |
| Richard J. Buchholz | Chief Financial Officer | $329,672 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael H. Carrel | Class III director | Appointed | 2026-07-24 |
| Casey Tansey | member of the Board of Directors | Retired | 2026-07-22 |
| Dana G. Mead, Jr. | Class II director | Appointed | 2026-05-05 |
| Georgia Melenikiotou | Class II director | Appointed | 2026-05-05 |
| Gary L. Ellis | Class II director | Appointed | 2026-05-05 |
| Richard J. Buchholz | interim Chief Financial Officer | Appointed | 2026-01-12 |
| Richard J. Buchholz | Chief Financial Officer | Resigned | 2025-08-26 |
| Randall A. Ban | Executive Vice President, Patient Access and Therapy Development | Retired | 2025-08-04 |
| Philip J. Ebeling | Chief Operating Officer | Resigned | 2024-07-22 |
| Timothy P. Herbert | Board Chair | Appointed | 2024-02-05 |
| Gary Ellis | Lead Independent Director | Appointed | 2024-02-05 |
| Marilyn Carlson Nelson | Chair of the Board of Directors | Retired | 2024-02-05 |
| Myriam J. Curet, M.D. | Class III director | Appointed | 2023-12-28 |
| Charisse Y. Sparks, M.D. | Chief Medical Officer | Appointed | 2023-08-01 |
| Charisse Y. Sparks, M.D. | Class III director | Appointed | 2022-08-02 |
| Cynthia Burks | Class II director | Appointed | 2022-08-02 |
Leadership
- Timothy P. Herbert Chairman
- Phil Ebeling COO
- Bryan K. Phillips General Counsel
- Charisse Y. Sparks Board Member
- Charisse Y. Sparks, M.D. Board Member
- Cynthia Burks Board Member
- Dana G. Mead, Jr. Board Member
- Gary Ellis Board Member
- Gary L. Ellis Board Member
- Georgia Garinois-Melenikiotou Board Member
- Georgia Melenikiotou Board Member
- Michael H. Carrel Board Member
- Myriam J. Curet, M.D. Board Member
- Shelley Broader Board Member
Key facts
CIK
1609550
CUSIP
457730109
13F (30d)
35 filings
34 filers
Visit website
Investor relations